68Ga-Pentikra PET/CT Imaging Study in Healthy Subjects

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

Healthy Volunteers

Interventions

DIAGNOSTIC_TEST

68Ga-Pentikra PET/CT Scan

68Ga-Pentikra Injection, Intravenous, administered at 0.05 mCi/kg by weight.

Trial Locations (1)

Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China, Xi'an, Shaanxi Province, Xi'an

All Listed Sponsors

lead

Xijing Hospital

OTHER

NCT06856109 - 68Ga-Pentikra PET/CT Imaging Study in Healthy Subjects | Biotech Hunter | Biotech Hunter